U.S. Markets open in 55 hrs, 1 min
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 8,280.74 | -223.32 | -2.63% |
| NASDAQ | 1,796.52 | -49.20 | -2.67% |
| S&P 500 | 896.42 | -26.91 | -2.91% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 33.77 10:09 AM EDT | |
|---|---|---|
| Day High | 34.27 01:38 PM EDT |
|
| Range | 0.50 |
| Volume | 1.46 M | |
|---|---|---|
| 30-Day Avg Vol | 1.75 M |
|
| Difference | -16.86% |
| Market Cap | 5.87 B | |
|---|---|---|
| Mkt Cap Chg | -105.60 M |
| Shares Out | 173.12 M | |
|---|---|---|
| % Shrs Traded | 0.84% | |
| 1yr EPS Est | -3.062 |
| 52-Wk Low | 18.43 10/28/08 | |
|---|---|---|
| 52-Wk High | 36.30 6/29/09 |
|
| Range | 17.87 |
| Prev Close | 34.56 7/1/09 | |
|---|---|---|
| Today's Open | 34.13 | |
| Change | -1.24% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 17.26 M |
| Revenue (LFY) | 175.50 M | |
|---|---|---|
| Earnings (LFY) | -459.85 M | |
| Earnings (MRQ) | -162.67 M | |
| Next Earn Est | -0.835 | |
| Next Earnings | 07/27/2009 |
|
| EPS (TTM) | -3.59 | |
| 1yr EPS Growth | 14.71% |
| P/E Ratio (TTM) | — | |
|---|---|---|
| P/E Ratio (Fwd) | -11.00 | |
| PEG Ratio | — | |
| Return on Equity | -180.61 | |
| Beta | 0.66 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
Vertex Pharmaceuticals represents the convergence of drug discovery technologies. The biotechnology company uses an integrated, multidisciplinary approach -- employing biophysics, computer-based modeling, ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | -0.835 7/27/09 | — — |
—
—
|
| Last Quarter | -0.821 3/31/09 | -1.04 3/31/09 |
-0.219
Missed
|
| 2 Quarters Ago | -0.929 12/31/08 | -0.96 12/31/08 |
-0.031
Missed
|
| Quarterly - 03/31/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 23.98 M | 175.50 M |
| Gross Profit | 13.24 M | 127.62 M |
| Operating Income | -151.70 M | -458.38 M |
| Net Income | -162.67 M | -459.85 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts